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Abstract
Background: Cherubism is a rare hereditary multi-cystic disease of the jaws, characterized by its
typical appearance in early childhood, and stabilization and remission after puberty. It is genetically
transmitted in an autosomal dominant fashion and the gene coding for SH3-binding protein 2
(SH3BP2) may be involved.
Case presentation: We investigated a family consisting of 21 members with 3 female affected
individuals with cherubism from Northern China. Of these 21 family members, 17 were recruited
for the genetic analysis. We conducted the direct sequence analysis of the SH3BP2 gene among
these 17 family members. A disease-causing mutation was identified in exon 9 of the gene. It was
an A1517G base change, which leads to a D419G amino acid substitution.
Conclusion: To our knowledge, the A1517G mutation has not been reported previously in
cherubism. This finding is novel.
Background
Cherubism (MIM 118400) is an autosomal dominant
inherited disease of the jaws. The lesion was first described
by Jones in 1933 as a hereditary multilocular cystic disease
of the jaws, characterized by symmetrically swollen
cheeks, particularly over the angles of the mandible, and
an upward turning of the eyes. The author coined the
descriptive term cherubism in 1938 because the typical
appearance resembled cherubism found in Renaissance
art [1]. The affected mandible and maxilla begin to swell
in early childhood, and are gradually increased until the
age of puberty [2]. The WHO has classified cherubim as a
non-neoplastic bone lesion. According to a latest litera-
ture search, there have been about 200 cases reported pre-
viously, including some sporadic cases [3].
The characteristic radiographic findings in cherubism are
well-defined as being multilocular areas of diminished
density, often very extensive, with a few irregular bony
septa. In the adult, the multilocular rarefactions become
replaced by sclerosis, with progressive calcification [4].
The dysplasia histologically consists of a mononuclear
fibroblastic stroma with large numbers of multinucleated
giant cells and cyst formation [5], but the characteristic
perivascular collagen cuffing is sometimes present. At the
periphery of the lesions, there may be newly formed oste-
oid and bones. Such a histological feature can be distin-
guished from other giant cell-rich lesions as it has been
found only in the jaws of patients with cherubism. In
addition to the typical histological features, therefore, the
bilateral involvement of the jaws, the typical course, and
the familial occurrence of the disease are required for the
diagnosis of cherubism.
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The gene responsible for cherubism has been mapped to
the region of chromosome 4p16.3 [6,7]. Point mutations
in the gene coding for SH3BP2 have been identified in 12
of 15 families. All the mutations identified so far are
present in exon 9 of the gene and cause amino acid substi-
tutions within a 6-amino acid sequence [8]. Several stud-
ies of cherubism have been reported in Chinese families,
but the work is restricted to clinical description only [9-
11]. In the present study, therefore, we attempted to per-
form the direct sequence analysis of the SH3BP2 gene in a
family with multiple affected individuals with cherubism
to see if there would be a novel mutation causing the ill-
ness in the Chinese family.
Case presentation
Subjects
A family consisting of 21 biologically related members, 3
of whom were female patients with cherubism, was iden-
tified in Northern China. Seventeen members were
recruited for the present study as four male members II-8,
II-1, III-1 and III-4 were missing. As shown in Figure 1,
affected member II-7 was the proband of cherubism, aged
41 years, with a slowly progressive upward displacement
of both eyes and an intraorbital mass bilaterally (Figure
2A). An irregular mandible was noticed at the age of 10
years. Her facial appearance was typically cherubic. Radi-
ological examinations demonstrated bilateral multi-cystic
lesions both in mandible and in maxilla compatible with
cherubism. She was promptly referred to a maxillofacial
service. An incisional biopsy was performed. Histological
examination revealed many giant cells in a vascularized
fibrous stroma. The diagnosis of cherubism was con-
firmed, and surgical operations, such as curettage and
osteoplasty, were then performed. Although cherubism is
generally self-limiting and subsides with age, the patient
described here was unusual in that the orbital involve-
ment arose in adulthood after the jaw lesions had sub-
sided. A physical examination revealed symmetrical
enlargement of the jaws, exophthalmos with diplopia and
a slight upward turning of the eyes (Figure 2A). The man-
dibular angles were also observed (Figure 2B). Her visual
activity and field were impaired. Computed tomography
(CT) scans showed bilateral multi-cystic lesions in the
maxilla and mandible (Figure 2C). The CT scans also
revealed that the lesions consisted mainly of soft tissue
masses with a ballooned cortex. Furthermore, the lesion
of the both maxilla extended into the orbit and then
affected the eyeball position (Figure 2C). However, there
was no sign of compression of the optic canal by the
lesion. Three-dimensional CT scans revealed that the sym-
metrically expanded anterior walls of the maxilla and the
symmetrically expanded mandible had a soap bubble
appearance as described previously by James and co-
workers [2] (Figure 2D).
The affected member II-9 is a sister of the member II-7,
aged 37 years. She was diagnosed as having cherubism at
the age of 7 years and she had fibrous dysplastic tissue
Pedigree of the family with three female affected individuals Figure 1
Pedigree of the family with three female affected individuals. The filled symbol represents the affected individuals and the arrow 
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Facial appearances and panoramic radiophotographic findings of affected member II-7 Figure 2
Facial appearances and panoramic radiophotographic findings of affected member II-7. The facial appearances show a symmet-
rical swelling of the cheeks and an exophthalmos (A) as well as the mandibular angles (B). Computed tomography scans show 
bilateral lesional tissue expanding the anteriorwall of the maxilla and the body of the mandible (C). Three-dimensional com-
puted tomography shows a remarkable expansion of the mandible, which can lead to a soap bubble appearance and the bilat-
eral bulges of the maxilla (D).
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curetted from her bilateral mandibles. A pathological
examination confirmed clusters of multinucleated giant
cells within a fibrous stroma, consistent with the diagno-
sis of cherubism. Because she had undergone a surgery
operation, her facial appearances looked well when her
sample was taken for this study (Figure 3A and 3B). How-
ever, the jaw panoramic radiophotography showed partial
calcifications of anterior mandible and mandibular angles
(Figure 3C).
The affected member III-7 is the daughter of the member
II-9, aged 14 years. She developed bilateral cystic lesions
of the mandible when she was 8 or 9 years old. At the age
of 9 years, there were visible lesions over the bilateral
mandibular angles and radiographs showed symmetric
multi-cystic lesions. Osteoplasty of the affected jaws was
performed. Her facial appearances did not show severe
abnormalities (Figure 4A and 4B) although the jaw pano-
ramic radiophotography revealed symmetric multi-cystic
alterations and impacted right mandibular canine teeth.
Defect of left mandibular canine, second molar teeth and
tooth root was also observed (Figure 4C).
To identify a disease-causing mutation, we also recruited
100 unrelated healthy subjects as control for DNA analy-
sis.
All the subjects gave written informed consent for the
present study, including clinical examinations, blood col-
lection and genetic analysis. Written consent was also
obtained from the patients and their relatives for publica-
tion of study. This study was approved by the local insti-
tutional review boards.
Sequencing of the SH3BP2 gene
Genomic DNA for the genetic analysis was extracted from
peripheral venous blood samples by conventional meth-
ods. The primers used for PCR amplification of exon 9 of
the gene were designed based on its DNA sequence (acces-
sion numbers NT003023 and NM006081), including 5'-
TgA gCT TTT TAg ggT CAC Agg-3'and 5'-ggC TTT ACA Tgg
TgC TgT gT-3'. The PCR amplification was performed in a
25-μL reaction volume containing 100 ng of genomic
DNA, 2.5 μL of 10X PCRx amplification buffer, 2.5 μL of
2.5 mM of dNTP mixture, 10 μM of each primer, and 1.0
U of Taq DNA polymerase. The conditions used for the
PCR amplification included denaturation at 94°C for 30
seconds, followed by 40 cycles at 94°C for 30 seconds,
62°C for 30 seconds and 72°C for 30 seconds, and final
elongation at 72°C for 8 minutes. The purified PCR prod-
ucts were used as templates for direct sequencing by a flu-
orescent dye-terminator cycle sequencing method with an
ABI PRISM Big Dye terminator cycle sequencing ready
reaction kit (Applied Biosystems, USA). Nucleotide
sequences were determined by an ABI 3730 XL automated
DNA sequencer (Applied Biosystems, USA).
Identification of mutations
Genomic DNA sequencing was performed in all 17 sub-
jects recruited in this study. A missense mutation was
identified in exon 9 of the SH3BP2 gene in patients with
cherubism. It was an A1517G base change, which leads to
the D419G amino acid substitution. Of 17 family mem-
bers, the A1517G base change was shown only in 3
affected individuals (affected members II-7, II-9 and III-
7). We did not observe such a mutation in 100 unrelated
controls. It is very likely that the A1517G base change is a
disease-causing mutation.
Conclusion
In this study, we identified a missense mutation at the
SH3BP2 gene in a Chinese family with multiple affected
individuals with cherubism. To our knowledge, this muta-
tion has not been reported previously. This is a novel find-
ing.
Since disease-causing mutations identified so far are all
located in exon 9 of the gene, which can result in amino
acid substitutions within a six-amino acid sequence, it can
be concluded that exon 9 of the SH3BP2 gene is a muta-
tion hotspot for cherubism. However, apart from the
dominant cases, in which the mutation of the SH3BP2
gene may be the only genetic cause for cherubism, the dis-
ease sometimes occurs sporadically. A recent study has
failed to identify a mutation within the SH3BP2 gene in
the case of a 14-year-old boy with grade I cherubism diag-
nosed late [12]. Possibly, the other candidate genes may
also be involved and the recessive pattern of inheritance
cannot be ruled out in some cases.
Moreover, the present work demonstrates that the
A1517G base change is shown only in three female
patients whereas expressivity of the disease varies based
on their facial appearances and panoramic radiophoto-
graphic findings (Figures 2, 3 and 4). All normal subjects
and healthy relatives have failed to show such a point
mutation. This finding seems to be inconsistent to the
hypothesis of incomplete penetrance in females although
Anderson and McClendon (1962) have reported that pen-
etrance of cherubism is 100% in males and 50–70% in
females [13]. Possibly, the mutation site affects the pene-
trance in females although abnormal inactivation of the X
chromosome cannot be ruled out.
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Facial appearances and panoramic radiophotographic findings of affected member II-9 Figure 3
Facial appearances and panoramic radiophotographic findings of affected member II-9.
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Facial appearances and panoramic radiophotographic findings of affected member III-7 Figure 4
Facial appearances and panoramic radiophotographic findings of affected member III-7.
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